Nuclear factor kappa B (NF-κB), a transcription factor that participates in the inflammatory cascade associated with NAFLD, was found to be an essential target for BBR [153]. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.